FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064064932> ?p ?o ?g. }

• W2064064932 endingPage "580" @default.
• W2064064932 startingPage "571" @default.
• W2064064932 abstract "•Stable drug binding in the channel pore inhibits the influenza A M2 channel. •Mutations in M2 perturb drug binding stability. •Structural biology and molecular simulations guide drug design for mutant M2 channels. •The M2 pore-binding site can bind to inhibitors of varying sizes. The type A influenza virus matrix protein 2 (M2) is a highly selective proton channel in the viral envelope. Because of its crucial role in viral infection and replication, the M2 channel has been a target of anti-influenza drugs. Due to the occurrence of drug-resistant mutations in the M2 channel, existing anti-influenza drugs that block the M2 channel, such as amantadine and rimantadine, have lost their efficacy against these mutant channels. Recent experimental and computational efforts have made great progress in understanding the drug resistance mechanisms of these mutations as well as designing novel drug candidates to block the mutant M2 channels. In this review, we briefly summarize the structural characteristics of the M2 channel, and then we discuss these recent studies on drug resistance and drug design of the mutant channels, focusing on the structures and energetics. We show that structural biology experiments and molecular modeling have led to the successful design of novel drugs targeting mutant M2 channels. The type A influenza virus matrix protein 2 (M2) is a highly selective proton channel in the viral envelope. Because of its crucial role in viral infection and replication, the M2 channel has been a target of anti-influenza drugs. Due to the occurrence of drug-resistant mutations in the M2 channel, existing anti-influenza drugs that block the M2 channel, such as amantadine and rimantadine, have lost their efficacy against these mutant channels. Recent experimental and computational efforts have made great progress in understanding the drug resistance mechanisms of these mutations as well as designing novel drug candidates to block the mutant M2 channels. In this review, we briefly summarize the structural characteristics of the M2 channel, and then we discuss these recent studies on drug resistance and drug design of the mutant channels, focusing on the structures and energetics. We show that structural biology experiments and molecular modeling have led to the successful design of novel drugs targeting mutant M2 channels." @default.
• W2064064932 created "2016-06-24" @default.
• W2064064932 creator A5041491902 @default.
• W2064064932 creator A5070612393 @default.
• W2064064932 creator A5073585518 @default.
• W2064064932 date "2013-10-01" @default.
• W2064064932 modified "2023-10-03" @default.
• W2064064932 title "Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel" @default.
• W2064064932 cites W1585610099 @default.
• W2064064932 cites W1966438745 @default.
• W2064064932 cites W1969651682 @default.
• W2064064932 cites W1970603365 @default.
• W2064064932 cites W1970985518 @default.
• W2064064932 cites W1972112708 @default.
• W2064064932 cites W1973524672 @default.
• W2064064932 cites W1974105617 @default.
• W2064064932 cites W1974452612 @default.
• W2064064932 cites W1974744451 @default.
• W2064064932 cites W1980318325 @default.
• W2064064932 cites W1987413552 @default.
• W2064064932 cites W1988031737 @default.
• W2064064932 cites W1989764838 @default.
• W2064064932 cites W1989788129 @default.
• W2064064932 cites W1994015011 @default.
• W2064064932 cites W2001099462 @default.
• W2064064932 cites W2004124445 @default.
• W2064064932 cites W2004313038 @default.
• W2064064932 cites W2007517640 @default.
• W2064064932 cites W2008601231 @default.
• W2064064932 cites W2009397538 @default.
• W2064064932 cites W2013129155 @default.
• W2064064932 cites W2013767643 @default.
• W2064064932 cites W2014763114 @default.
• W2064064932 cites W2016207186 @default.
• W2064064932 cites W2026828269 @default.
• W2064064932 cites W2028372889 @default.
• W2064064932 cites W2030634427 @default.
• W2064064932 cites W2033677091 @default.
• W2064064932 cites W2034419471 @default.
• W2064064932 cites W2037087307 @default.
• W2064064932 cites W2037831301 @default.
• W2064064932 cites W2038560260 @default.
• W2064064932 cites W2043901383 @default.
• W2064064932 cites W2045053284 @default.
• W2064064932 cites W2049956191 @default.
• W2064064932 cites W2050585153 @default.
• W2064064932 cites W2051894265 @default.
• W2064064932 cites W2054929943 @default.
• W2064064932 cites W2056136433 @default.
• W2064064932 cites W2060899129 @default.
• W2064064932 cites W2061027258 @default.
• W2064064932 cites W2063012912 @default.
• W2064064932 cites W2065093984 @default.
• W2064064932 cites W2071135420 @default.
• W2064064932 cites W2071298986 @default.
• W2064064932 cites W2074034360 @default.
• W2064064932 cites W2074499311 @default.
• W2064064932 cites W2079298235 @default.
• W2064064932 cites W2084355438 @default.
• W2064064932 cites W2085163163 @default.
• W2064064932 cites W2087087296 @default.
• W2064064932 cites W2098864163 @default.
• W2064064932 cites W2099344204 @default.
• W2064064932 cites W2099822880 @default.
• W2064064932 cites W2108107193 @default.
• W2064064932 cites W2112404890 @default.
• W2064064932 cites W2116211618 @default.
• W2064064932 cites W2133085299 @default.
• W2064064932 cites W2135553224 @default.
• W2064064932 cites W2138198678 @default.
• W2064064932 cites W2140597030 @default.
• W2064064932 cites W2143784163 @default.
• W2064064932 cites W2148618424 @default.
• W2064064932 cites W2155734592 @default.
• W2064064932 cites W2162316896 @default.
• W2064064932 cites W2167063739 @default.
• W2064064932 cites W2170259317 @default.
• W2064064932 cites W2172027067 @default.
• W2064064932 cites W2329794147 @default.
• W2064064932 cites W2332119174 @default.
• W2064064932 doi "https://doi.org/10.1016/j.tips.2013.08.003" @default.
• W2064064932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24011996" @default.
• W2064064932 hasPublicationYear "2013" @default.
• W2064064932 type Work @default.
• W2064064932 sameAs 2064064932 @default.
• W2064064932 citedByCount "36" @default.
• W2064064932 countsByYear W20640649322014 @default.
• W2064064932 countsByYear W20640649322015 @default.
• W2064064932 countsByYear W20640649322016 @default.
• W2064064932 countsByYear W20640649322017 @default.
• W2064064932 countsByYear W20640649322018 @default.
• W2064064932 countsByYear W20640649322019 @default.
• W2064064932 countsByYear W20640649322020 @default.
• W2064064932 countsByYear W20640649322021 @default.
• W2064064932 countsByYear W20640649322022 @default.
• W2064064932 countsByYear W20640649322023 @default.
• W2064064932 crossrefType "journal-article" @default.
• W2064064932 hasAuthorship W2064064932A5041491902 @default.

• next